Document is current
Any future updates will be listed below
-
Authors
Hannigan, Alannah
Krishnan, Nandini
Singh, Kirti
Bytelaar, Shannon
Schmitz, Deb
Bartlett, Sofia
Hall, David
Barrios, Rolando
Montaner, Julio S. G.
Harris, Marianne
Hull, Mark W.
Salters, Kate A.
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 4 February 2025
First Online: 13 February 2025
Declarations
:
: The study protocol is approved by the University of British Columbia and Providence Health Care Ethics Review Board (H21-01534). The University of British Columbia’s Research Ethics Boards review and oversee such research to assure that it meets ethical principles and that it complies with all applicable regulations and guidelines pertaining to human participant protection. The Hep C Connect study adhered to the Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Informed consent to participate in the study was obtained from all participants at time of enrolment.
: Not applicable.
: JSGM is the Executive Director and Physician-in-Chief of the BC Centre for Excellence in HIV/AIDS, a provincial program serving all BC health authorities, and based at St. Paul’s Hospital-Providence Health Care. JM’s Treatment as Prevention® (TasP®) research, paid to his institution, has received support from the BC Ministry of Health, Health Canada, Canadian Institutes of Health Research, Public Health Agency of Canada, Genome Canada, Genome BC, Vancouver Coastal Health and Vancouver Hospital Foundation. Institutional grants have been provided by Gilead Sciences Inc, Janssen, Merck Sharp & Dohme LLC, and ViiV Healthcare.
